These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6664153)

  • 1. PQ-intervals and serum concentrations as indices of verapamil absorption following sublingual, buccal and per oral administration in man.
    Woodcock BG; Asthana OP; Wenchel M; Rietbrock N
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):537-41. PubMed ID: 6664153
    [No Abstract]   [Full Text] [Related]  

  • 2. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
    Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
    Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].
    Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH
    Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.
    John DN; Fort S; Lewis MJ; Luscombe DK
    Br J Clin Pharmacol; 1992 Jun; 33(6):623-7. PubMed ID: 1389935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.
    Karim A; Piergies A
    Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.
    Dali MM; Moench PA; Mathias NR; Stetsko PI; Heran CL; Smith RL
    J Pharm Sci; 2006 Jan; 95(1):37-44. PubMed ID: 16307454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
    Schaff EA; DiCenzo R; Fielding SL
    Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of S-verapamil after single doses of two different galenic formulations of racemic verapamil.
    Harder S; Siewert M; Thürmann P; Blume H; Rietbrock N; Siewert B
    Arzneimittelforschung; 1993 May; 43(5):520-2. PubMed ID: 8328995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.
    Eichelbaum M; Birkel P; Grube E; Gütgemann U; Somogyi A
    Klin Wochenschr; 1980 Sep; 58(18):919-25. PubMed ID: 7206587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of verapamil and norverapamil during long-term oral therapy.
    Tartaglione TA; Pieper JA; Lopez LL; Mehta J
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):15-27. PubMed ID: 6867470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic comparison of oral and intravenous verapamil in atrial fibrillation.
    Follath F; Fromer M; Meier P; Vozeh S
    Clin Invest Med; 1980; 3(1-2):49-52. PubMed ID: 7009004
    [No Abstract]   [Full Text] [Related]  

  • 18. Sublingual and oral morphine administration. Review and new findings.
    Robison JM; Wilkie DJ; Campbell B
    Nurs Clin North Am; 1995 Dec; 30(4):725-43. PubMed ID: 7501539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal absorption of verapamil-evidence for membrane storage [proceedings].
    Davis BJ; Johnston A
    Br J Clin Pharmacol; 1979 Apr; 7(4):434P. PubMed ID: 444383
    [No Abstract]   [Full Text] [Related]  

  • 20. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.